Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases

NCT00098605 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Central Nervous System Metastases
HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer
Tumors Metastatic to Brain

Interventions

DRUG: lapatinib ditosylate
OTHER: laboratory biomarker analysis
PROCEDURE: quality-of-life assessment
OTHER: questionnaire administration

Sponsor

National Cancer Institute (NCI)